Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05916677
Other study ID # TOM-VR-DM1
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date October 30, 2023
Est. completion date July 2024

Study information

Verified date November 2023
Source Institut de Myologie, France
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The ability of an individual to conceive some alternative representations and to behave in a flexible manner would emerge from preschool age and drastically improve between the ages of 3 and 5 (Doebel and Zelazo, 2013). They constitute, according to Diamond (2013), a prerequisite for the development of the Theory of Mind (ToM). Deficits in Executive Functions (EF) may therefore interfere with the child's ability to understand and adapt to social situations. Treatment failures are often observed when traditional cognitive tools are used. This would be linked to the divergence between non-immersive tests and situations encountered in everyday life (Damasio, 1994; Priore Castelnuovo and Liccione, 2002). For this reason, an increasing number of researchers are using virtual reality for the rehabilitation of executive functions and Theory of Mind in patients with neurodevelopmental pathology (Millen, Edlin-White and Cobb, 2010) or brain damage (Le Gall, Besnard, Louisy, Richard and Allain 2008). There is currently no systematic evaluation of ToM in children with the infantile form of DM1 even though these abilities are considered particularly vulnerable and have a decisive impact on the subsequent development of interpersonal relationships. This research will focus on studying the socio-emotional disorders associated with the infantile form of Myotonic Dystrophy type 1 (DM1). The axis that we propose to develop more specifically will be an interventional study with the aim of remediation with children from 5 to 16 years old suffering from the infantile form of DM1 via a training protocol in low-immersion Virtual Reality (VR) centered on emotional processing and theory of mind.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 95
Est. completion date July 2024
Est. primary completion date July 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Years to 16 Years
Eligibility Inclusion Criteria: - 6 years and < 16 years of age - Written informed consent - Affiliate or beneficiary of a social security scheme - Able to comply with all protocol requirements - Infantile form of DM1 with molecular confirmation. - Development without incident in the first year - Normal development in the pre and neonatal period - Native language French Exclusion Criteria: - Unable to participate in the study - Inability to comply with protocol requirements - Congenital form of DM1 - IQ<70 (Intellectual Disability)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Virtual Reality-training in Theory of Mind
Two social scenarios will be used in a virtual environement. Experimenter and subject participate in the scenario as friends of the main character, Nicolas. During the training session, experimenter asks structured questions about participant's awareness of a mental state. In the case of a wrong answer, a feedback-correction is provided via the avatar's thought bubbles. The participant has access to all avatars thought bubbles. In this way, he is able to compare the desires, beliefs or false beliefs of each story character. Participants included in this condition will also have an eye-tracking assessment before and after the training procedure.
Traditional training in Theory of Mind
The same two social scenarios are presented to the participant in a story-telling form. Participant has access to thought bubbles via an illustrated book. These trainings will take place in the same number of sessions and took place for a duration equivalent to those used in low immersion Virtual Reality mode. Each training session (EFB, BE, SOFB, ERA, FP, EFP) will be illustrated via visual aids taken from screenshots of the two virtual environments and the target protagonists.

Locations

Country Name City State
France Institut de Psychologie Boulogne-Billancourt

Sponsors (1)

Lead Sponsor Collaborator
Institut de Myologie, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary NEPSY II Emotion Recognition and Standardized ToM Through study completion, an average of 5 weeks
Secondary WISC-V Wechsler Scale is the international benchmark for measuring children's intelligence Through study completion, on average 5 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT00082108 - Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
Completed NCT02308657 - Multicenter Observational Study of Myotonic Dystrophy Type 1 N/A
Enrolling by invitation NCT06316778 - Pelvic Floor Muscle Training for Women With Myotonic Dystrophy N/A
Completed NCT02312011 - A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1 Phase 1/Phase 2
Recruiting NCT02269865 - Children's Health Research Institute(CHRI), Stanford Lucile Packard Children Hospital (LPCH) Protocol on Myotonic Dystrophy N/A
Completed NCT00577577 - Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1 Phase 2
Completed NCT02831504 - PhenoDM1 (Myotonic Dystrophy Type 1 Natural History Study)
Recruiting NCT06075693 - Cerebrospinal Fluid Biomarkers of Myotonic Dystrophy
Completed NCT02118779 - Observational Prolonged Trial in Myotonic Dystrophy Type 1 N/A